You are here

Home

Medicon

Company Information
Address
12 Baylor Cir
White Plains, NY 10605-3006
United States
Information

UEI: Y2MJPAK4EDL3

# of Employees: 0
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 6

  1. A Novel Agent for Ovarian Cancer

    Amount: $300,000.00

    ABSTRACT Epithelial ovarian cancer EOC is the main subgroup of ovarian cancer the most lethal gynecological malignancy EOC encompasses high grade serous epithelial ovarian carcinoma fallopian tu ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health

  2. MDC-1231 for cancer prevention

    Amount: $1,803,865.00

    DESCRIPTION (provided by applicant): The chemoprevention of colon cancer has been hampered by either weak agents or significant side effects. It was recently shown that the combination of sulindac wi ...

    STTRPhase II2012Department of Health and Human Services National Institutes of Health

  3. An agent for the treatment of lung cancer

    Amount: $299,999.00

    DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer deaths in the US and worldwide. Given its prevalence, morbidity and mortality, it is clear that in terms of treatment, ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health

  4. Not Available

    Amount: $199,899.00

    We propose studies for the preclinical development of BJ-813, a novel agent against breast cancer. BJ-813 has significant activity in vitro (human breast cancer cell lines covering the clinical spectr ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health

  5. MDC-1231 for cancer prevention

    Amount: $187,534.00

    DESCRIPTION (provided by applicant): Strong evidence supports the notion that chemoprevention has the potential to be a major component of colorectal cancer control. The prevention of cancer depends h ...

    STTRPhase I2010Department of Health and Human Services National Institutes of Health

  6. Novel Urea Breath Test for H. Pylori Diagnosis

    Amount: $149,800.00

    DESCRIPTION (provided by applicant): We propose to develop a novel method for the diagnosis of Helicobacter pylori. The diagnosis of H. pylori infection is a high medical priority because: this bacter ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government